MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with G

Gemfibrozil

Gemfibrozil 300mg capsules

Use with caution

Stability notes for Gemfibrozil 300mg capsules

Store in airtight containers. Protect from moisture.

Provenance

This compatibility recommendation is derived from Lopid 300mg capsules (Pfizer Ltd).

Supplier

Lopid 300mg capsules (Pfizer Ltd)

Gemfibrozil 600mg tablets

Use with caution

Stability notes for Gemfibrozil 600mg tablets

Store in airtight containers.

Provenance

This compatibility recommendation is derived from Lopid 600mg tablets (Pfizer Ltd).

Suppliers (9) of Gemfibrozil 600mg tablets
Gemfibrozil 600mg tablets (A A H Pharmaceuticals Ltd)
Gemfibrozil 600mg tablets (Alliance Healthcare (Distribution) Ltd)
Gemfibrozil 600mg tablets (CST Pharma Ltd)
Gemfibrozil 600mg tablets (Phoenix Healthcare Distribution Ltd)
Gemfibrozil 600mg tablets (Sigma Pharmaceuticals Plc)
Gemfibrozil 600mg tablets (Tillomed Laboratories Ltd)
Lopid 600mg tablets (CST Pharma Ltd)
Lopid 600mg tablets (Pfizer Ltd)
Lopid 600mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.